"
Characterization of Genomic Events Other than Ph and Evaluation of Prognostic Influence on Imatinib in Chronic Myeloid Leukemia (CML): A Study on 1449 Patients from India"
written by P. S. Kadam Amare, H. Jain, S. Kabre, D. Walke, H. Menon, M. Sengar, N. Khatri, B. Bagal, U. Dangi, H. Jain, P. G. Subramanian, S. Gujral,
published by
Journal of Cancer Therapy,
Vol.7 No.4, 2016
has been cited by the following article(s):
[1]
|
Control of Ph+ and additional chromosomal abnormalities in chronic myeloid leukemia by tyrosine kinase inhibitors
Medical Oncology,
2023
DOI:10.1007/s12032-023-02116-4
|
|
|
[2]
|
Chromosomal Instability in Chronic Myeloid Leukemia: Mechanistic Insights and Effects
Cancers,
2022
DOI:10.3390/cancers14102533
|
|
|
[3]
|
Chronic myeloid leukemia with complex karyotypes: Prognosis and therapeutic approaches
Journal of Cellular Physiology,
2019
DOI:10.1002/jcp.27505
|
|
|
[4]
|
Chronic myeloid leukemia with complex karyotypes: Prognosis and therapeutic approaches
Journal of Cellular Physiology,
2019
DOI:10.1002/jcp.27505
|
|
|